Secondly, relative to SMT plus sham-NPPV/SMT alone, NPPV improved plasma BNP level but did not improve LVEDD and decrease threats of cardiac arrest events, angina, and AMI events. The gene discussed is NPPB; the disease is cardiac arrest.